Chemoinformaics analysis of BETA-ELEMOL
Molecular Weight | 222.372 | nRot | 3 |
Heavy Atom Molecular Weight | 196.164 | nRig | 8 |
Exact Molecular Weight | 222.198 | nRing | 1 |
Solubility: LogS | -3.015 | nHRing | 0 |
Solubility: LogP | 3.807 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 42 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 1 |
No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 15 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 43.1886 |
nHD | 1 | BPOL | 26.0834 |
QED | 0.717 |
Synth | 4.178 |
Natural Product Likeliness | 3.031 |
NR-PPAR-gamma | 0.004 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.017 |
Pgp-sub | 0 |
HIA | 0.005 |
CACO-2 | -4.369 |
MDCK | 0.0000183 |
BBB | 0.89 |
PPB | 0.819717 |
VDSS | 1.359 |
FU | 0.098177 |
CYP1A2-inh | 0.05 |
CYP1A2-sub | 0.5 |
CYP2c19-inh | 0.069 |
CYP2c19-sub | 0.922 |
CYP2c9-inh | 0.178 |
CYP2c9-sub | 0.567 |
CYP2d6-inh | 0.022 |
CYP2d6-sub | 0.671 |
CYP3a4-inh | 0.423 |
CYP3a4-sub | 0.308 |
CL | 5.137 |
T12 | 0.163 |
hERG | 0.01 |
Ames | 0.003 |
ROA | 0.018 |
SkinSen | 0.062 |
Carcinogencity | 0.054 |
EI | 0.948 |
Respiratory | 0.519 |
NR-Aromatase | 0.014 |
Antiviral | Yes |
Prediction | 0.838314 |